EXCLUSIVE LICENSE AND DISTRIBUTION AGREEMENTExclusive License and Distribution Agreement • December 13th, 2010 • Cel Sci Corp • Biological products, (no disgnostic substances) • New York
AMENDED AND RESTATED EXCLUSIVE LICENSE AND DISTRIBUTION AGREEMENTExclusive License and Distribution Agreement • May 4th, 2006 • Electric Aquagenics Unlimited Inc • Specialty cleaning, polishing and sanitation preparations • Florida
THIS AMENDED AND RESTATED EXCLUSIVE LICENSE AND DISTRIBUTION AGREEMENT (the “Agreement”) is entered into as of the 1st day of May, 2006 (the “Effective Date”) by and between Electric Aquagenics Unlimited, Inc., a Delaware corporation having its principal offices located at 1464 West 40 South, Lindon, UT 84042 (“Licensor”), and Water Science, LLC, a limited liability company having its principal offices located at 1800 N.W. 89th Place, Miami, Florida 33172 (the “Licensee”).
EXCLUSIVE LICENSE AND DISTRIBUTION AGREEMENTExclusive License and Distribution Agreement • February 12th, 2018 • MITU Resources Inc. • Gold and silver ores • Nevada
THIS EXCLUSIVE LICENSE AND DISTRIBUTION AGREEMENT (this “Agreement”), effective as of February ___, 2018, (the “Effective Date”), by and between Mitu Resources Inc., a corporation organized and existing under the laws of the State of Nevada (“Licensee”), and the HeadWind Technologies Ltd., a company formed under the laws of Canada (“Supplier”) (each of Licensee and Supplier, are hereinafter referred to as a “Party” or collectively the “Parties”).
CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.Exclusive License and Distribution Agreement • November 8th, 2013 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations
THIS EXCLUSIVE LICENSE AND DISTRIBUTION AGREEMENT (hereinafter, this ‘Agreement’) is made effective as of the 23rd day of July, 2013.
AMENDMENT I TO EXCLUSIVE LICENSE AND DISTRIBUTION AGREEMENTExclusive License and Distribution Agreement • May 30th, 2018 • Nuo Therapeutics, Inc. • Surgical & medical instruments & apparatus
This AMENDMENT I (“Amendment”) is made and entered into as of May 28, 2018 (“Amendment Effective Date”), between Nuo Therapeutics, Inc., a Delaware corporation, with its principal office at 207A Perry Parkway, Suite 1, Gaithersburg, MD 20877 (“Nuo”), and Rohto Pharmaceutical Co., Ltd., a Japanese company, with its principal office at 1-8-1 Tatsumi-nishi, Ikuno-ku, Osaka 544-8666, Japan (“Rohto”). Each of Nuo and Rohto is hereinafter referred to as a “Party” and collectively the “Parties.”
AMENDMENT No. 3 TO EXCLUSIVE LICENSE AND DISTRIBUTION AGREEMENTExclusive License and Distribution Agreement • February 10th, 2009 • Geospatial Holdings, Inc. • Services-direct mail advertising services
This Amendment No. 3 (“Amendment No.3”) to that Exclusive License and Distribution Agreement entered into as of the 3rd day of August 2006, by and between REDUCT NV, a company organized and existing under the laws of Belgium, with registered office at Molenborglei 42, 2627 Schelle, Belgium (“Reduct” or the “Company”‘). and GEOSPATIAL MAPPING SYSTEMS, INC., a corporation incorporated under the laws of the State of Delaware, USA, with registered office at 229 Howes Run Road, Sarver, Pennsylvania USA 16055 (‘Geospatial”), as modified and extended by that Agreement entered into as of the 6th day June, 2007 (the “Extension Agreement”) by and among the Company, Geospatial and, for the limited purposes set forth therein, DELTA NETWORKS LIMITED SA, a company incorporated under the laws of Luxembourg and the owner of the outstanding capital stock of the Company (“Delta Networks”), and Mark A. Smith (“Smith”), and as modified by Amendment No. 1 entered into as of December 21, 2007 (“Amendment No
EXCLUSIVE LICENSE AND DISTRIBUTION AGREEMENTExclusive License and Distribution Agreement • May 1st, 2008 • Geospatial Holdings, Inc. • Services-direct mail advertising services
THIS EXCLUSIVE LICENSE AND DISTRIBUTION AGREEMENT (the “Agreement”) is made as of the 3rd day of August, 2006, by and between REDUCT NV (further called “Company”), a company organised and existing under the laws of Belgium with registered office at Satenrozen la, Box 2, 2550 Kontich, Belgium, and GEOSPAT1AL MAPPING SYSTEMS, INC., a company incorporated under the laws of the state of Delaware, with registered office at 229 Howes Run Road, Sarver, Pennsylvania, USA 16055 (further called “Geospatial”), the Company and Geospatial agree as follows:
CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN EXCLUDED PURSUANT TO REGULATION S-K, ITEM 601(B)(10). SUCH EXCLUDED INFORMATION IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. EXCLUSIVE LICENSE AND...Exclusive License and Distribution Agreement • September 13th, 2023 • Quoin Pharmaceuticals, Ltd. • Surgical & medical instruments & apparatus
This License and Distribution Agreement (this “Agreement”), dated as of September 1, 2023 (“Effective Date”), is by and between by and between Quoin Pharmaceuticals, Ltd., a Delaware corporation located at 42127 Pleasant Forest Court, Ashburn, VA 20148 (“Quoin”) and Farma Mondo SA, a company incorporated under the laws of Switzerland located at Via Indipendenza 3b, 6830 Chiasso, Switzereland (“Licensee”). Quoin and Licensee are sometimes referred to herein individually as a “Party,” and together as the “Parties.”
EXCLUSIVE LICENSE AND DISTRIBUTION AGREEMENTExclusive License and Distribution Agreement • September 11th, 2013 • Sanwire Corp • Gold and silver ores • Nevada
THIS AGREEMENT (the “Agreement”), is entered into as of January 2, 2013 (the “Effective Date”) by and between Naiel Kanno, a businessman residing in 5900 Muir Drive, Unit# 41, Richmond, BC V6V 2Y8, (the “Licensor”) and NT Mining Corporation, a corporation incorporated in Nevada (the “Licensee”) (each individually a “Party”, collectively the “Parties”).
ContractExclusive License and Distribution Agreement • October 30th, 2007 • Alpharma Inc • Pharmaceutical preparations
Exhibit 10.8 - Confidential Materials Omitted And Filed Separately With The Securities And Exchange Commission. Asterisks Denote Omissions
EXCLUSIVE LICENSE AND DISTRIBUTION AGREEMENTExclusive License and Distribution Agreement • June 5th, 2018 • Sonoma Pharmaceuticals, Inc. • Pharmaceutical preparations • England
Sonoma Pharmaceuticals, Inc., a company incorporated and existing under the laws of the State of Delaware, USA, having its registered offices at 1129 North McDowell Boulevard, Petaluma, California, 94954, United States of America, hereby represented by its legal representatives
FITTECH, LLC EXCLUSIVE LICENSE AND DISTRIBUTION AGREEMENTExclusive License and Distribution Agreement • April 21st, 2010 • Nextfit, Inc. • Services-business services, nec • Texas
This EXCLUSIVE LICENSE AND DISTRIBUTION AGREEMENT (the “License Agreement”) is entered into effective April 15, 2010 (the “Effective Date’) by and between FitTech, LLC, a Delaware limited liability company with its principal offices at 1900 McKinney, #2711, Dallas, Texas 75201 (the “Licensor”) and NextFit, Inc., f/k/a Wren, Inc., a Nevada corporation with principal offices at 235 West Sego Lily, 2nd Floor, Sandy, Utah 84070 (the “Licensee”).
FIRST AMENDED AND RESTATED EXCLUSIVE LICENSE AND DISTRIBUTION AGREEMENT FOR RECTOGESIC® Between STRAKAN INTERNATIONAL LIMITED And Cellegy Pharmaceuticals, Inc. ConfidentialExclusive License and Distribution Agreement • March 31st, 2006 • Cellegy Pharmaceuticals Inc • Pharmaceutical preparations • California
ProStrakan Group plc (“Group”) hereby unconditionally guarantees and undertakes to Cellegy that Licensee will duly and punctually observe and perform all the undertakings, covenants and obligations of Licensee under this Agreement (including the payment of any damages becoming due to Cellegy as a result of any breach by Licensee of such undertakings, covenants and obligations) and under any agreements between the Parties (or any of them) which are expressly supplemental to this Agreement or which this Agreement requires to be executed (the “Obligations”) to the intent that if Licensee shall fail for whatever reason so to observe and perform any Obligations, Group shall be liable to perform the same in all respects as if Group was the party principally bound thereby in place of Licensee on demand from Cellegy.
EXCLUSIVE LICENSE AND DISTRIBUTION AGREEMENTExclusive License and Distribution Agreement • October 24th, 2016 • Nuo Therapeutics, Inc. • Surgical & medical instruments & apparatus • Delaware
This EXCLUSIVE LICENSE AND DISTRIBUTION AGREEMENT (“Agreement”) is made and entered into as of May 5, 2016 (“Effective Date”), between NUO THERAPEUTICS, INC., a Delaware corporation, with principal office at 207A Perry Parkway, Suite 1, Gaithersburg, MD 20877 (“Nuo”), and BOYALIFE HONG KONG LTD., a China corporation, with its principal office at 800 Jiefang Road East, 14th Floor, Wuxi, China 214002 (“Boyalife”). Each of Nuo and Boyalife is hereinafter referred to as a “Party” and collectively the “Parties.”
EXCLUSIVE LICENSE AND DISTRIBUTION AGREEMENTExclusive License and Distribution Agreement • October 24th, 2016 • Nuo Therapeutics, Inc. • Surgical & medical instruments & apparatus • New York
This Exclusive License And Distribution Agreement (“Agreement”) is made and entered into as of December 31, 2014 (“Effective Date”), between Nuo therapeutics, Inc., (formerly Cytomedix Inc.) a Delaware corporation, with principal office at 207 Perry Parkway, Suite 1, Gaithersburg, MD 20877 (“Nuo”), and ROHTO Pharmaceutical Co., Ltd., a Japanese company, with its principal office at 1-8-1 Tatsumi-nishi, Ikuno-ku, Osaka 544-8666, Japan (“Rohto”). Each of Nuo and Rohto is hereinafter referred to as a “Party” and collectively the “Parties.”
ADDENDUM AND EXTENSION TO EXCLUSIVE LICENSE AND DISTRIBUTION AGREEMENTExclusive License and Distribution Agreement • April 2nd, 2009 • Wren, Inc. • Services-business services, nec
This ADDENDUM AND EXTENSION TO EXCLUSIVE LICENSE AND DISTRIBUTION AGREEMENT (this “Agreement”) is made effective 31 March 2009 (the “Effective Date”) by and among and NEXTFITNESS, INC., a Nevada corporation whose address is 235 West Sego Lily Drive, 2nd Floor, Sandy UT 84070 (“Licensor”) and WREN, INC., a Nevada corporation whose address is 235 W Sego Lily Dr., Sandy UT 84070 (“Licensee”),
AMENDMENT No. 2 TO EXCLUSIVE LICENSE AND DISTRIBUTION AGREEMENTExclusive License and Distribution Agreement • May 1st, 2008 • Geospatial Holdings, Inc. • Services-direct mail advertising services
This Amendment No. 2 (“Amendment”) to that Exclusive License and Distribution Agreement (the “License Agreement”) entered into as of the 3rd day of August, 2006, by and between REDUCT NV, a company organized and existing under the laws of Belgium, with registered office at Molenberglei 42, 2627 Schelle, Belgium (the “Company”), and GEOSPATIAL MAPPING SYSTEMS, INC., a corporation incorporated under the laws of the State of Delaware, USA, with registered office at 229 Howes Run Road, Sarver, Pennsylvania USA 16055 (“Geospatial”), as modified and extended by that Agreement entered into as of the 6th day June, 2007, by and among the Company, Geospatial and, for the limited purposes set forth therein, DELTA NETWORKS LIMITED SA, and a company incorporated under the laws of Luxembourg and the owner of the outstanding capital stock of the Company (“Delta Networks”), (the “Extension Agreement” and together with the License Agreement, the “Agreement”), and as modified by amendment No 1 entered i
EXCLUSIVE LICENSE AND DISTRIBUTION AGREEMENT THIS AGREEMENT (“Agreement”) is made this 22nd day of March, 2006 (“Effective Date”) BETWEEN Remedent, Inc. El Segundo, CA 90245 • USA - hereinafter referred to as “Manufacturer” - AND Mr. Kang Mr. Cho From...Exclusive License and Distribution Agreement • July 14th, 2006 • Remedent, Inc. • Dental equipment & supplies • California
The Manufacturer is the holder of the patents and licenses for the production and sale of all the Products (hereinafter defined). The Manufacturer will produce, supply, license and grant the Distributor the right of exclusive sale of the Products in the Territory. The Distributor undertakes to make its best efforts to commence distribution of all the Manufacturer’s products in the Territory after a successful filing with all necessary government and regulatory offices.
AMENDMENT No. 1 TO EXCLUSIVE LICENSE AND DISTRIBUTION AGREEMENTExclusive License and Distribution Agreement • May 1st, 2008 • Geospatial Holdings, Inc. • Services-direct mail advertising services
This Amendment No. 1 (“Amendment”) to that Exclusive License and Distribution Agreement (the “License Agreement”) entered into as of the 3rd day of August, 2006, by and between REDUCT NV, a company organized and existing under the laws of Belgium, with registered office at Satenrozen la, Box 2, 2550 Kontich, Belgium (the “Company”), and GEOSPATIAL MAPPING SYSTEMS, INC., a corporation incorporated under the laws of the State of Delaware, USA, with registered office at 229 Howes Run Road, Sarver, Pennsylvania USA 16055 (“Geospatial”) as modified and extended by that Agreement entered into as of the 6th day June, 2007, by and among the Company, Geospatial and, for the limited purposes set forth therein, and Mark A. Smith (“Smith”) (the “Extension Agreement” and together with the License Agreement, the “Agreement”), is entered as of December 21, 2007 (the “Effective Date”) by and among Company, Geospatial and, for the limited purposes described herein, Delta Networks and Smith. Any capital
EXCLUSIVE LICENSE AND DISTRIBUTION AGREEMENTExclusive License and Distribution Agreement • January 20th, 2022 • Sonoma Pharmaceuticals, Inc. • Pharmaceutical preparations • Georgia
This Exclusive License and Distribution Agreement is made and entered into as of January 18, 2022 (hereinafter the “Effective Date”) by and between:
SECOND ADDENDUM AND EXTENSION TO EXCLUSIVE LICENSE AND DISTRIBUTION AGREEMENTExclusive License and Distribution Agreement • May 7th, 2009 • Wren, Inc. • Services-business services, nec
This ADDENDUM AND EXTENSION TO EXCLUSIVE LICENSE AND DISTRIBUTION AGREEMENT (this “Agreement”) is made effective 1 May 2009 (the “Effective Date”) by and among and NEXTFITNESS, INC., a Nevada corporation whose address is 235 West Sego Lily Drive, 2nd Floor, Sandy UT 84070 (“Licensor”) and WREN, INC., a Nevada corporation whose address is 235 W Sego Lily Dr., Sandy UT 84070 (“Licensee”).
EXCLUSIVE LICENSE AND DISTRIBUTION AGREEMENT FOR RECTOGESIC™ BETWEEN STRAKAN INTERNATIONAL LIMITED AND CELLEGY PHARMACEUTICALS, INC. CONFIDENTIALExclusive License and Distribution Agreement • March 31st, 2005 • Cellegy Pharmaceuticals Inc • Pharmaceutical preparations • California
THIS EXCLUSIVE LICENSE AND DISTRIBUTION LICENSE AGREEMENT (this “Agreement”) is made and entered into as of December 9, 2004 (the “Effective Date”), by and between Cellegy Pharmaceuticals, Inc., a Delaware corporation having its principal place of business at 349 Oyster Point Boulevard, San Francisco, California 94080, US (“Cellegy”), and Strakan International Limited, a company organized and existing under the laws of Bermuda with a branch office at Buckholm Mill, Galashiels, TD1 2HB, UK (“Licensee”“).
EXCLUSIVE LICENSE AND DISTRIBUTION AGREEMENTExclusive License and Distribution Agreement • January 29th, 2014 • Well Power, Inc. • Refrigeration & service industry machinery • British Columbia
ME RESOURCE CORP., a corporation incorporated under the laws of the Province of British Columbia and having its head office at Suite 900 555 Burrard Street, Vancouver, British Columbia, Canada V7X 1M8.
Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if disclosed.] EXCLUSIVE LICENSE AND DISTRIBUTION AGREEMENTExclusive License and Distribution Agreement • November 9th, 2021 • Sonoma Pharmaceuticals, Inc. • Pharmaceutical preparations • Georgia
This Exclusive License and Distribution Agreement is made and entered into as of November 9, 2021 (hereinafter the “Effective Date”) by and between:
